NUclear MEdicine DIagnostic and Artificial Intelligence
ConditionHyperparathyroidism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de Besancon
About this trial
Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroid images and for the localization of parathyroid adenomas using artificial intelligence tools.
Inclusion criteria Patients having undergone a double isotope parathyroid diagnostic examination using the standard Besançon University Hospital protocol (double injection of 123I and 99mTc, pinhole image, low energy high resolution (LEHR) and (single-photon emission tomography / Computed tomography) SPECT/CT +/- (positron emission tomography (PET) Choline).
Secondary endpoints Concordance between diagnoses made by nuclear physicians using both methods (current method and new treatment method).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and women over 18 years of age who underwent dual-isotope parathyroid scintigraphy.
No refusal to use data for research purposes
Retrospective data (after 13/04/2022: Date of posting of patient information in the department) and prospective data
Disqualifiers
Patient refusal to use data for research purposes
Patients who did not benefit from the standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions)
Trial population
Men and women over 18 years of age who have undergone dual-isotope parathyroid scintigraphy (standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions).
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
treatment program
Devicethe study aims to set up an artificial intelligence diagnostic assistance program
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Development of an artificial intelligence diagnostic program
Development of an artificial intelligence diagnostic program
Time frame
through study completion, an average of 4 yearsSecondary outcomes
1
Development of an automatic program for subtracting double-isotope parathyroid images.
Development of an automatic program for subtracting double-isotope parathyroid images.
Time frame
through study completion, an average of 2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Universitaire de Besancon
Lead sponsor
Franche-Comté Electronique Mécanique Thermique et Optique - Sciences et Technologies, UMR 6174
Collaborator
Source ClinicalTrials.gov